Clinical Trial

Clinical Investigation of the Quality of Life Benefit of Using a Home Walking Exoskeleton for a Population of Multiple Sclerosis Patients.

Study acronym: EXHOMESEP
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical investigation is to evaluate the effectiveness of home use of a lightweight robotic lower limb exoskeleton as a walking aid device on quality of life in patients with multiple sclerosis with gait disorders. Participants will wear an exoskeleton (Keeogo) for 8 weeks at home during the experimental phase. This phase is compared to an 8-week control phase at home with advice on regular physical activity adapted to their abilities.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-04-18.
Status change: Not Yet Recruiting → Recruiting 2025-04-08
Trial Details
NCT Number NCT05835622
Lead Sponsor Pôle Saint Hélier
Conditions Multiple Sclerosis
Enrollment 28 participants
Start Date 2024-02-01
Primary Completion 2026-10 (estimated)
Study Completion 2026-10-02 (estimated)
Updated on ClinicalTrials.gov 2025-04-09